comparemela.com

James Bradner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Amgen shares pop 12% after excitement from obesity drug candidate | Pacific Coast Business Times

Amgen's new research and development facility in San Francisco. (courtesy photo) Shares of Thousand Oaks-based Amgen gained 12% on May 3, one day after the company disclosed its earnings for the first quarter of 2024 and highlighted the excitement around its weight-loss drug. During the company’s earnings call, Amgen CEO Bob Bradway commented on their

Amgen soars 16% after it talks up a new weight loss drug that could be injected monthly instead of weekly

Goldman Sachs said Amgen's experimental GLP-1 drug could have peak sales of $5 billion, or 5% of the estimated $100 billion weight loss drug market.

Amgen Stock Price Soars After It Hypes New Monthly Weight Loss Drug

Goldman Sachs said Amgen's experimental GLP-1 drug could have peak sales of $5 billion, or 5% of the estimated $100 billion weight loss drug market.

Amgen stock falls as analysts debate weight loss prospects (NASDAQ:AMGN)

Amgen stock falls as analysts debate weight loss prospects (NASDAQ:AMGN)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.